CHPA pushes back on FDA proposal to reverse oral phenylephrine's OTC status
The proposed order challenges FDA’s longstanding recognition of PE as a safe and effective treatment for nasal congestion.
CHPA
The proposed order challenges FDA’s longstanding recognition of PE as a safe and effective treatment for nasal congestion.